Our previous studies using fluorophore conjugated antibodies to CEA, CA 19–9, Kit, and MUC-1 have demonstrated their capability of brightly labeling gastrointestinal tumors in vivo [6,24,30,32–40]. Here, KIT is linked to digestive system neoplasm.